MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/eci.13883

Медицинская библиотека · European journal of clinical investigation · 2022

Statin-based endothelial prophylaxis and outcome after allogeneic stem cell transplantation.

Pabst Caroline, Schreck Nicholas, Benner Axel, Hegenbart Ute, Schönland Stefan, Radujkovic Aleksandar, Schmitt Michael, Müller-Tidow Carsten, Orsatti Laura, Dreger Peter, Luft Thomas

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Allogeneic haematopoietic stem cell transplantation (alloSCT) often remains the only curative therapy for hematologic malignancies. Although the management of transplant-associated adverse events considerably improved over the last decades, nonrelapse mortality (NRM) remains a challenge, and endothelial dysfunction was identified as a major contributor to NRM.

METHODS

Statin-based endothelial prophylaxis (SEP) has been implemented in the standard of care in our transplant centre to reduce NRM caused by endothelial injury. Here, we retrospectively analysed the impact of SEP on clinical outcome in a cohort of 347 alloSCT patients.

RESULTS

SEP (n = 209) was associated with significantly reduced NRM (hazard ratio 0.61, 95% CI 0.38-0.96) and better overall survival (OS) after acute graft-versus-host disease (HR 0.59, 95% CI 0.37-0.93). Subgroup analyses showed that the NRM benefit was mainly found in patients with an intermediate endothelial activation and stress index (EASIX), while relapse risk was not affected. On day 100 post-alloSCT, patients receiving SEP had significantly higher levels of the rate-limiting enzyme of tryptophan metabolism, indoleamine 2,3-dioxygenase (IDO), higher kynurenine to tryptophan ratios as a proxy of IDO activity and tended to have lower levels of the endothelial injury marker ST2 (p = .055). No significant differences in interferon-gamma or IL18 levels were observed. These biomarker signatures suggest that the beneficial effects of SEP might be mediated by both endothelial protection and immunomodulation.

CONCLUSIONS

Together, these data suggest that SEP improves NRM and OS post-alloSCT in particular in patients with intermediate endothelial risk and provide first mechanistic clues about its potential mode of action.

Для цитирования: Pabst Caroline, Schreck Nicholas, Benner Axel, Hegenbart Ute, Schönland Stefan, Radujkovic Aleksandar, Schmitt Michael, Müller-Tidow Carsten, Orsatti Laura, Dreger Peter, Luft Thomas. Statin-based endothelial prophylaxis and outcome after allogeneic stem cell transplantation.. European journal of clinical investigation. 2022. DOI: 10.1111/eci.13883.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.